The summit is a unique and by invitation-only conference designed around three important global issues for investors:
Key participants include CEOs & other Senior Executives from public and private healthcare and life science companies, along with senior partners from venture capital and private equity investors.
The Livingston Securities Healthcare and Life Science Summit will feature panelists from Pfizer, Wyeth, GSK, Boehringer-Ingelheim, GE Healthcare, Haemonetics, Baxter, IBM Healthcare, Oxford Bioscience Partners, CMEA Ventures, Harris & Harris Ventures, Yorkville Partners, EuclidSR, and more. International companies and investors will also represent the UK, France, Ireland, Italy and Singapore.
“Scott Livingston's debut conference focusing on Healthcare, Life Science and Nanotechnology was a tremendous success last year,” said Vincent Caprio, Vice President and Event Director, NanoBusiness Alliance. “I'm pleased to be working with Scott again this year for his second annual event, which will prove to be of even greater value to all participants and key stakeholders.”
The Summit will be chaired by Dr. Mostafa Analoui, Head of Healthcare & Life Sciences for the Livingston Group of Companies.
The Livingston Healthcare and Life Science Summit will be held on September 24, 2009 at the Lighthouse International Conference Center located at 111 East 59th Street, New York, NY 10022.
For details please contact Jonathan Mason “[email protected]” or visit our website at www.livingstonsecurities.com.